JP2002355065A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002355065A5 JP2002355065A5 JP2001330728A JP2001330728A JP2002355065A5 JP 2002355065 A5 JP2002355065 A5 JP 2002355065A5 JP 2001330728 A JP2001330728 A JP 2001330728A JP 2001330728 A JP2001330728 A JP 2001330728A JP 2002355065 A5 JP2002355065 A5 JP 2002355065A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- protein
- seq
- partial peptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000003839 salts Chemical class 0.000 claims 30
- 108090000623 proteins and genes Proteins 0.000 claims 23
- 102000004169 proteins and genes Human genes 0.000 claims 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims 13
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- 239000002157 polynucleotide Substances 0.000 claims 6
- 102000040430 polynucleotide Human genes 0.000 claims 6
- 108091033319 polynucleotide Proteins 0.000 claims 6
- 238000012216 screening Methods 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 230000000692 anti-sense effect Effects 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 239000000032 diagnostic agent Substances 0.000 claims 2
- 229940039227 diagnostic agent Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 210000000805 cytoplasm Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001330728A JP2002355065A (ja) | 2000-10-30 | 2001-10-29 | 心臓および骨格筋で高発現する新規遺伝子およびその用途 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000331401 | 2000-10-30 | ||
| JP2000-331401 | 2000-10-30 | ||
| JP2001330728A JP2002355065A (ja) | 2000-10-30 | 2001-10-29 | 心臓および骨格筋で高発現する新規遺伝子およびその用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002355065A JP2002355065A (ja) | 2002-12-10 |
| JP2002355065A5 true JP2002355065A5 (ru) | 2005-06-16 |
Family
ID=26603083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001330728A Withdrawn JP2002355065A (ja) | 2000-10-30 | 2001-10-29 | 心臓および骨格筋で高発現する新規遺伝子およびその用途 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002355065A (ru) |
-
2001
- 2001-10-29 JP JP2001330728A patent/JP2002355065A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McPhalen et al. | Calcium-binding sites in proteins: a structural perspective | |
| Taubman et al. | Cloning and characterization of mammalian myosin regulatory light chain (RLC) cDNA: the RLC gene is expressed in smooth, sarcomeric, and nonmuscle tissues. | |
| JP2005516072A5 (ru) | ||
| ATE419537T1 (de) | Verwendung eines polypeptids zur auffindung von multipler sklerose | |
| EP2093298A3 (en) | Compositions for diagnosis and therapy of diseases associated with aberrant expression of Futrins (R-Spondins) | |
| CN101454341B (zh) | 表面核仁素的多价合成配体在治疗癌症或发炎中的用途 | |
| RU2008102731A (ru) | Новое биологическое вещество несфатин, родственные ему вещества и их применение | |
| WO2002032953A3 (en) | Pregnancy-associated plasma protein-a2 (papp-a2) | |
| RU2006132384A (ru) | Слитые белки альбумина | |
| EP1284297A3 (en) | Identification and use of molecules implicated in pain | |
| JP2003000270A5 (ru) | ||
| JP2008518622A5 (ru) | ||
| JP2002355065A5 (ru) | ||
| ITRM950273A1 (it) | Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni | |
| DE69925116D1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. | |
| WO2003076658A3 (en) | A susceptibility gene for late-onset idiopathic parkinson's disease | |
| EP2032601B1 (en) | Peptides regulating the surface expression of the t cell receptor | |
| EP1693456A4 (en) | GENE ENCODING A G PROTEIN-COUPLED RECEPTOR AND ASSOCIATED GENE PRODUCT | |
| JP2005512509A5 (ru) | ||
| JP2005006644A5 (ru) | ||
| WO1997026276B1 (en) | Vertebrate fringe proteins | |
| JP2003144177A5 (ru) | ||
| WO2004085469A3 (en) | Secreted protein family | |
| JP2004081196A5 (ru) | ||
| JP2002335976A5 (ru) |